Inventor · disambiguated record
Seokjoong Kim
Also filed as: KIM SEOKJOONG
8 granted patents·7 pending applications·32 citations·filing 2013–2023
79Inventor score
Top patents by PatentIndex Score
15 records- 0189US10846864B2Method and apparatus for detecting gesture in user-based spatial coordinate systemVTOUCH CO LTD·Filed 2017·Granted Nov 24, 2020·29 cites·15 claims
- 0274US12486521B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2023·Granted Dec 2, 2025·0 cites·13 claims
- 0372US11441135B2Target-specific CRISPR mutantTOOLGEN INC·Filed 2018·Granted Sep 13, 2022·1 cites·6 claims
- 0469US12163149B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2022·Granted Dec 10, 2024·0 cites·5 claims
- 0569US10796694B2Optimum control method based on multi-mode command of operation-voice, and electronic device to which same is appliedVTOUCH CO LTD·Filed 2018·Granted Oct 6, 2020·2 cites·21 claims
- 0668US2015284727A1Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereofTOOLGEN INC·Filed 2013·Application pending·0 cites
- 0766US11999952B2Artificially-manipulated neovascularization regulatory systemTOOLGEN INC·Filed 2021·Granted Jun 4, 2024·0 cites·11 claims
- 0862US2023130858A1Target-specific crispr mutantTOOLGEN INC·Filed 2022·Application pending·0 cites
- 0960US11572574B2Artificial genome manipulation for gene expression regulationTOOLGEN INC·Filed 2020·Granted Feb 7, 2023·0 cites·15 claims
- 1058US11667934B2Platform for expressing protein of interest in liverTOOLGEN INC·Filed 2018·Granted Jun 6, 2023·0 cites·15 claims
- 1154US2025051749A1Novel promoter and use thereofTOOLGEN INC·Filed 2022·Application pending·0 cites
- 1248US2018237771A1Artificially-Manipulated Neovascularization Regulatory SystemTOOLGEN INC·Filed 2018·Application pending·0 cites
- 1345US2023044581A1Learning-based power modeling of a processor core and systems with multiple processor coresXILINX INC·Filed 2021·Application pending·0 cites
- 1441US2020263204A1Composition for treating hemophilia a by crispr/cas system of reverting fviii gene inversionTOOLGEN INC·Filed 2018·Application pending·0 cites
- 1541US2020101173A1Genome Editing System For Repeat Expansion MutationTOOLGEN INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seokjoong Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →